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Novel chiral stationary phases
The principle of reciprocity introduced by Pirkle proposes that if a single molecule of a chiral
substance has different affinities for the enantiomers of another chiral molecule, then single
enantiomers of the latter can be used to select enantiomers of the former. Bringing this
principle together with combinatorial chemistry has led to the development of novel chiral
stationary phases suitable for the resolution of drug molecules (K. Lewandowski et al., J.C.S.
Chem. Commun., (1998), 2237-2238).
Initially a combinatorial library of 4-aryl-1,4-dihydropyrimidines (DHPM) was prepared in
solution using the Biginelli multicomponent reaction. Applying the large range of available
precursors allowed the production of 140 racemic products which were screened against a
chiral molecule, (S)-(3,5-dinitrobenzoyl)leucine, attached to polymeric resin beads. By
applying retention times of the enantiomers to calculate the separation factor, α, it was evident
that the racemic mixtures were separated to different degrees by the chiral stationary phase. In
particular, the highest values of α were achieved for two DHPMs (1 and 2).
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Single enantiomers of these particular DHPMs were then employed in the production of chiral
stationary phases by attachment to a solid support. Columns packed with these materials (3)
have proven to be highly effective at separating a number of different chiral substances
including amino acid, non-steroidal anti-inflammatory drugs and dihydropyrimidines.
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Cathepsin D inhibitors from libraries
Aspartyl proteases are a ubiquitous class of enzyme. The presence of many of these enzymes
has been implicated in disease, and potent and selective inhibitors may offer opportunities for
therapy. A recent paper describes the use of combinatorial chemistry in the search for
inhibitors of cathepsin D, an enzyme that plays a role in breast tumour metastasis (C.E. Lee et
al., J. Am. Chem. Soc., (1998), 120, 9735-9747).
Known inhibitors of aspartyl proteases usually employ a secondary alcohol as a mimic of the
tetrahedral intermediate in peptide hydrolysis, and consequently this functional group was
maintained as an invariant part of the library structures. Using a solid-phase synthetic
approach, key intermediates were linked to the support through the secondary alcohol, and the
synthesis designed such that four sidechains in the products (4) could be varied. In particular,
a method for the variation of P1 sidechain has been developed.
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A library of 204 compounds was synthesised and the compounds screened for cathepsin D
inhibition. Many of the most potent analogues were resynthesised on a larger scale and several
of these had Ki values of below 3 nM. This synthetic approach is now being used for a study
of the inhibitors that bind to the malarial protease plasmepsins I and II.
--------------------------------------------------------------------------------------------------------------
Inhibitors of Protein Farnesyltransferase
Ras proteins are found in a large proportion of human tumours. The Ras protein needs to
undergo a number of post-translational modifications to be able to function, one of which is
farnesyltransferase-mediated farnesylation. Thus, inhibition of this enzyme is a possible method
for blocking the uncontrolled mitogenic signalling pathway. Many inhibitors have been
previously reported, but these have limited utility due to the presence of a vulnerable thiol
residue. Combinatorial chemistry has been applied in the discovery of protein
farnesyltransferase inhibitors that lack the thiol group (D.J. Augeri et al, J. Med. Chem.,
(1998), 41, 4288-4300).
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A number of derivatives of the Wang resin-linked derivative (5) were synthesised leading
ultimately to a 64 nM lead (6). This compound had limited activity in a cell-based assay, and
routine medicinal chemistry was used in the discovery of more potent farnesyltransferase
inhibitors that inhibited Ras processing in whole cells.
